SCHEMBL4345871

SCHEMBL4345871

O=C(Nc1ccccc1C(F)(F)F)N(S)c1cc(Cl)ccc1O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.51
GAA P10253 2/20 0.46
TP53 P04637 2/20 0.46
TMPRSS4 Q9NRS4 4/20 0.45
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4356224 0.91 GRIK1 (0.51) GRIK1GAATP53TMPRSS4KMT2A
SCHEMBL4347517 0.85 GRIK1 (0.45) GRIK1GAATP53KMT2AKDM4E
SCHEMBL4353239 0.81 KMT2A (0.43) GRIK1GAAKMT2AKDM4EPOLB
SCHEMBL4342177 0.81 TRPV1 (0.50) GRIK1GAAKMT2AKDM4EPOLB
SCHEMBL2838246 0.80 CHRNA7 (0.63) TMPRSS4KMT2ACYP1A2CYP2C19TRPV1
SCHEMBL4346890 0.80 KMT2A (0.43) GRIK1GAATMPRSS4KMT2AKDM4E
SCHEMBL4354228 0.79 GRIK1 (0.40) GRIK1GAATP53KMT2AKDM4E
SCHEMBL4342062 0.78 TMPRSS4 (0.55) GRIK1TP53TMPRSS4KMT2AMAPT
SCHEMBL4353933 0.78 TMPRSS4 (0.60) GRIK1TMPRSS4KMT2A
SCHEMBL4353761 0.78 ALDH1A1 (0.44) GRIK1GAAKMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 GRIK1 21/4885GAA 4010/4885TP53 4868/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 GRIK1 54/4885GAA 3384/4885TP53 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.